Singapore markets open in 5 hours 12 minutes
Straits Times Index
3,330.81 +0.80 (+0.02%) S&P 500
5,351.67 -2.36 (-0.04%) Dow
38,890.37 +83.04 (+0.21%) Nasdaq
17,169.18 -18.72 (-0.11%) Bitcoin USD
70,713.91 -453.51 (-0.64%) CMC Crypto 200
1,514.49 -10.31 (-0.67%)
Centessa Pharmaceuticals plc (CNTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:48PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 994.79M |
| Enterprise value | 850.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 125.09 |
| Price/book (mrq) | 4.62 |
| Enterprise value/revenue | 124.13 |
| Enterprise value/EBITDA | 1.12 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.40 |
| 52-week change 3 | 90.89% |
| S&P500 52-week change 3 | 24.69% |
| 52-week high 3 | 12.45 |
| 52-week low 3 | 4.50 |
| 50-day moving average 3 | 9.68 |
| 200-day moving average 3 | 8.22 |
Share statistics
| Avg vol (3-month) 3 | 210.79k |
| Avg vol (10-day) 3 | 178.66k |
| Shares outstanding 5 | 113.04M |
| Implied shares outstanding 6 | 113.85M |
| Float 8 | 71.01M |
| % held by insiders 1 | 2.05% |
| % held by institutions 1 | 77.36% |
| Shares short (15 May 2024) 4 | 1.76M |
| Short ratio (15 May 2024) 4 | 7.18 |
| Short % of float (15 May 2024) 4 | 1.99% |
| Short % of shares outstanding (15 May 2024) 4 | 1.56% |
| Shares short (prior month 15 Apr 2024) 4 | 1.28M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,312.80% |
Management effectiveness
| Return on assets (ttm) | -27.06% |
| Return on equity (ttm) | -54.45% |
Income statement
| Revenue (ttm) | 6.85M |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -158.14M |
| Net income avi to common (ttm) | -138.42M |
| Diluted EPS (ttm) | -1.42 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 230.18M |
| Total cash per share (mrq) | 2.04 |
| Total debt (mrq) | 86.07M |
| Total debt/equity (mrq) | 40.00% |
| Current ratio (mrq) | 10.37 |
| Book value per share (mrq) | 2.14 |
Cash flow statement
| Operating cash flow (ttm) | -149.79M |
| Levered free cash flow (ttm) | -92.71M |
© 2024 Yahoo. All rights reserved.